It is absurd to believe that a single phase III study of Optina lasting just 12 weeks will be sufficient to seek FDA approval as a treatment for DME. Will tank like PSDV, ALIM...FDA will be harsh.
There seeking approval for Ampion! Too bad your short trying to cover.
Sentiment: Strong Buy
I think you need to do more research. You have it wrong
The FDA meeting has nothing to do with Optina... its a meeting on Ampion.